In vitro antidiabetic potential of the fruits of Crataegus pinnatifida

Research in Pharmaceutical Sciences

Volumn 9, Issue 1, 2014, Pages 11-22

  Chowdhury, S S ^a   Islam, M N ^a   Jung, H A ^b   Choi, J S ^a,c  

^a Pukyong National University   (South Korea)

^b Chonbuk National University   (South Korea)

^c Dong Eui University   (South Korea)

Author keywords

3 epicorosolic acid; Antidiabetic activity; Crataegus pinnatifida; Kinetics

Indexed keywords

3 EPICOROSOLIC ACID; ACARBOSE; ACETIC ACID ETHYL ESTER; ADVANCED GLYCATION END PRODUCT; ALDEHYDE REDUCTASE; ALPHA GLUCOSIDASE; AMINOGUANIDINE; ANTIDIABETIC AGENT; CHLOROGENIC ACID; CRATAEGUS PINNATIFIDA EXTRACT; DICHLOROMETHANE; HYPERIN; METHANOL; OLEANOLIC ACID; PLANT EXTRACT; PLANT MEDICINAL PRODUCT; PROTEIN TYROSINE PHOSPHATASE 1B; QUERCETIN; SITOGLUSIDE; SITOSTEROL; UNCLASSIFIED DRUG; URSOLIC ACID;

ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ARTICLE; CONTROLLED STUDY; CRATAEGUS PINNATIFIDA; DIABETES MELLITUS; DRUG POTENCY; ENZYME INHIBITION; FRUIT; IC 50; IN VITRO STUDY; LENS; NONHUMAN; RAT;

EID: 84886419442     PISSN: 17355362     EISSN: 17359414     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Matsui T, Tanaka T, Tamura S, Toshima A, Tamaya K, Miyata Y, et al. Alpha-glucosidase inhibitory profile of catechins and theaflavins. J Agric Food Chem. 2007;55:99-105.
2. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87:4-14.
3. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001;414:813-820.
4. Ghadyale V, Takalikar S, Haldavnekar V, Arvindekar A. Effective control of postprandial glucose level through inhibition of intestinal alpha glucosidase by Cymbopogon martinii (roxb.). Evid Based Complement Alternat Med. 2012;2012:1-6.
5. Chaisson JL. Acarbose for the prevention of diabetes, hypertension, and cardiovascular disease in subjects with impaired glucose tolerance: the study to prevent non-insulin-dependent diabetes mellitus (STOP-NIDDM). Endocr Pract. 2006;12:25-30.
6. Giannoukakis N. Ranirestat as a therapeutic aldose reductase inhibitor for diabetic complications. Expert Opin Investig Drugs. 2008;17:575-581.
7. Fujisawa T, Ikegami H, Inoue K, Kawabata Y, Ogihara T. Effect of two α-glucosidase inhibitors, voglibose and acarbose, on postprandial hyperglycemia correlates with subjective abdominal symptoms. Metabolism. 2005;54:387-390.
8. Singh SK, Rai PK, Jaiswal D, Watal G. Evidence based critical evaluation of glycemic potential of Cynodon dactylon. Evid Based Complement Alternat Med. 2008;5:415-420.
9. Zhang ZS, Ho WKK, Huang Y, Chen ZY. Hypocholesterolemic activity of hawthorn fruit is mediated by regulation of cholesterol-7α-hydroxylase and acyl CoA: cholesterol acyltransferase. Food Res Int. 2002;35:885-891.
10. Chu CY, Lee MJ, Liao CL, Lin WL, Yin YF, Tseng TH. Inhibitory effect of hot-water extract from dried fruit of Crataegus pinnatifida on low-density lipoprotein (LDL) oxidation in cell and cell-free systems. J Agric Food Chem. 2003;51:7583-7588.
11. Chen JD, Wu YZ, Tao ZL, Chen ZM, Liu XP. Hawthorn (shan zha) drink and its lowering effect on blood lipid levels in humans and rats. World Rev Nutr Diet. 1995;77:147-154.
12. Kao ES, Wang CJ, Lin WL, Yin YF, Wang CP, Tseng TH. Anti-inflammatory potential of flavonoid content from dried fruits of Crataegus pinnatifida in vitro and in vivo. J Agric Food Chem. 2005;53:430-436.
13. Kao ES, Wang CJ, Lin WL, Chu CY, Tseng TH. Effects of polyphenols derived from fruits of Crataegus pinnatifida on cell transformation, dermal edema and skin tumor formation by phorbol ester application. Food Chem Toxicol. 2007;45:795-804.
14. Li C, Son HJ, Huang C, Lee SK, Lohakare J, Wang MH. Comparison of Crataegus pinnatifida Bunge var.typica Schneider and C. pinnatifida Bunge fruits for antioxidant, anti-α-glucosidase, and antiinflammatory activities. Food Sci Biotechnol. 2010;19:769-775.
15. Li H, Song F, Xing J, Rong T, Liu Z, Liu S. Screening and structural characterization of α-glucosidase inhibitors from Hawthorn leaf flavonoids extract by ultrafiltration LC-DAD-MSn and SORI-CID FTICR MS. J Am Soc Mass Spectrom. 2009;20:1496-1503.
16. Kuoa DH, Yehb CH, Shieha PC, Chengc KC, Chena FA, Cheng JT. Effect of ShanZha, a Chinese herbal product, on obesity and dyslipidemia in hamsters receiving high-fat diet. J Ethnopharmacol. 2009;124:544-550.
17. Kwok CY, Wong CNY, Yau MYC, Yua PHF, Au ALS, Poon CCW, et al. Consumption of dried fruit of Crataegus pinnatifida (hawthorn) suppresses high-cholesterol diet-induced hypercholesterolemia in rats. J Functional Foods. 2010;2:179-186.
18. Lin Y, Vermeer MA, Trautwein EA. Triterpenic acids present in hawthorn by inhibiting intestinal ACAT activity in hamsters. Evid Based Complement Alternat Med. 2009;2011:1-9.
19. Li T, Zhang XD, Song YW, Liu JW. A microplatebased screening method for α-glucosidase inhibitors. Chin J Clin Pharmacol Ther. 2005;10:1128-1134.
20. Cui L, Na M, Oh H, Bae EY, Jeong DG, Ryu SE, et al. Protein tyrosine phosphatase 1B inhibitors from Morus root bark. Bioorg Med Chem Lett. 2006;16:1426-1429.
21. Hayman S, Kinoshita JH. Isolation and properties of lens aldose reductase. J Biol Chem. 1965;240:877-882.
22. Vinson JA, Howard TB III. Inhibition of protein glycation and advanced glycation endproducts by ascorbic acid and other vitamins and nutrients. J Nutr Biochem. 1996;7:659-663.
23. th ed. Oxford: Wiley-Blackwell; 2010. p. 238.
24. Tonks NK. PTP1B: from the sidelines to the front lines!. FEBS Lett. 2003;546:140-148.
25. Kusari J, Kenner KA, Shu KI, Hill DE, Henry RR. Skeletal muscle protein tyrosine phosphatase activity and tyrosine phosphatase 1B protein content are associated with insulin action and resistance. J Clin Invest. 1994;93:1156-1162.
26. Ahmad F, Azevedo JJ, Cortright R, Dohm G, Goldstein B. Alteration in skeletal muscle proteintyrosine phosphatase activity and expression in insulin-resistant human obesity and diabetes. J Clin Invest. 1997;100:449-458.
27. Kinoshita JH, Varma SD, Fukui HN. Aldose reductase in diabetes. Jpn J Ophthalmol. 1976;20:399-410.
28. Kubo E, Miyoshi N, Fukuda M, Akagi Y. Cataract formation through the polyol pathway is associated with free radical production. Exp Eye Res. 1999;68:457-464.
29. Kador PF, Kinoshita JH, Tung WH, Chylack LT. Differences in the susceptibility of various aldose reductases to inhibition. II. Invest Ophthalmol Vis Sci. 1980;19:980-982.
30. Reddy VP, Beyaz A. Inhibitors of the Maillard reaction and AGE breakers as therapeutics for multiple diseases. Drug Discov Today. 2006;11:646-654.
31. Thorpe SR, Baynes JW. Maillard reaction products in tissue proteins: new products and new perspectives. Amino Acids. 2003;25:275-281.
32. Ahmed N. Advanced glycation endproducts-role in pathology of diabetic complications. Diabetes Res Clin Pract. 2005;67:3-21.
33. Thomas MC, Baynes JW, Thorpe SR, Cooper ME. The role of AGEs and AGE inhibitors in diabetic cardiovascular disease. Curr Drug Targets. 2005;6:453-474.
34. Wada R, Yagihashi S. Role of advanced glycation end products and their receptors in development of diabetic neuropathy. Ann N Y Acad Sci. 2005;1043:598-604.
35. Muthusamy VS, Saravanababu C, Ramanathan M, Raja RB, Sudhagar S, Anand S, et al. Inhibition of protein tyrosine phosphatase 1B and regulation of insulin signalling markers by caffeoyl derivatives of chicory (Cichorium intybus) salad leaves. Br J Nutr. 2010;104:813-823.
36. Kim J, Jeong IH, Kim CS, Lee YM, Kim JM, Kim JS. Chlorogenic acid inhibits the formation of advanced glycation end products and associated protein cross-linking. Arch Pharm Res. 2011;34:495-500.
37. Kim CS, Kim J, Lee YM, Sohn E, Jo K, Kim JS. Inhibitory effects of chlorogenic acid on aldose reductase activity in vitro and cataractogenesis in galactose-fed rats. Arch Pharm Res. 2011;34:847-852.
38. Lee J, Jang DS, Yoo NH, Lee YM, Kim JH, Kim JS. Single-step separation of bioactive flavonol glucosides from Osteomeles schwerinae by highspeed counter-current chromatography. J Sep. Sci. 2010;33:582-586.
39. Beaulieu LP, Harris CS, Saleem A, Cuerrier A, Haddad PS, Martineau LC, et al. Inhibitory effect of the Cree traditional medicine wiishichimanaanh (Vaccinium vitis-idaea) on advanced glycation endproduct formation: identification of active principles. Phytother Res. 2010;24:741-747.
40. Fan P, Terrier L, Hay AE, Marston A, Hostettmann K. Antioxidant and enzyme inhibition activities and chemical profiles of Polygonum sachalinensis F. Schmidt ex Maxim (Polygonaceae). Fitoterapia. 2010;81:124-131.
41. Kang W, Zhang L, Song Y. α-Glucosidase inhibitors from Luculia pinciana. Zhongguo Zhong Yao Za Zhi. 2009;34:406-409.
42. Thuong PT, Lee CH, Dao TT, Nguyen PH, Kim WG, Lee SJ, et al. Triterpenoids from the leaves of Diospyros kaki (Persimmon) and their inhibitory effects on protein tyrosine phosphatase 1B. J Nat Prod. 2008;71:1775-1778.
43. Na M, Yang S, He L, Oh H, Kim BS, Oh WK, et al. Inhibition of protein tyrosine phosphatase 1B by ursane-type triterpenes isolated from Symplocos paniculata. Planta Med. 2006;72:261-263.
44. Yin MC, Chan KC. Non-enzymatic antioxidative and antiglycative effects of oleanolic acid and ursolic acid. J Agric Food Chem. 2007;55:7177-7181.
45. Wang ZH, Hsu C, Huang CC, Yin MC. Antiglycative effects of oleanolic acid and ursolic acid in kidney of diabetic mice. Eur J Pharmacol. 2010;628:255-260.